Literature DB >> 28986854

Altered Epigenetic Mechanisms in Thyroid Cancer Subtypes.

Maryam Zarkesh1, Azita Zadeh-Vakili2, Fereidoun Azizi3, Forough Foroughi4, Maziar Mohammad Akhavan5, Mehdi Hedayati6.   

Abstract

Thyroid carcinoma (TC) is the most frequent malignant neoplasm of the endocrine system. Molecular methods for diagnosis of invasive thyroid disease can be effectively adopted. Epigenetic factors play an important role in the diversity patterns of gene expression and the phenotypic and biological characteristics of TC subtypes. We aimed to review epigenetic changes in the main subtypes of TC, along with a presentation of the methods that have examined these changes, and active clinical trials for the treatment of advanced TCs targeting epigenetic changes. A literature analysis was performed in MEDLINE using PubMed, Elsevier, and Google Scholar for studies published up to 2016, using the keywords: "Epigenetic alterations" OR "Epigenetic changes", "thyroid cancers", "papillary thyroid cancer", "medullary thyroid cancer", "follicular thyroid cancer", and "anaplastic thyroid cancer", which resulted in 310 articles in English. All related abstracts were reviewed and studies were included that were published in English, had available full text, and determined the details of the methods and materials associated with the epigenetic patterns of TC and its subtypes (100 articles). Analysis of epigenetic alterations in TC subtypes helps to identify pathogenesis and can play an important role in the classification and diagnosis of tumors. Epigenetic mechanisms, especially aberrant methylation of DNA and microRNAs (miRs), are likely to play an important role in thyroid tumorigenesis. Further studies are required to elucidate the role of histone modification mechanisms in TC development.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28986854     DOI: 10.1007/s40291-017-0303-y

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN: 1177-1062            Impact factor:   4.074


  114 in total

1.  MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.

Authors:  Hong-Ming Song; Yi Luo; Deng-Feng Li; Chuan-Kui Wei; Kai-Yao Hua; Jia-Lu Song; Hui Xu; Niraj Maskey; Lin Fang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

2.  The role of microRNA genes in papillary thyroid carcinoma.

Authors:  Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

Review 3.  Poorly differentiated and anaplastic thyroid cancer.

Authors:  Kepal N Patel; Ashok R Shaha
Journal:  Cancer Control       Date:  2006-04       Impact factor: 3.302

4.  Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells.

Authors:  M Göttlicher; S Minucci; P Zhu; O H Krämer; A Schimpf; S Giavara; J P Sleeman; F Lo Coco; C Nervi; P G Pelicci; T Heinzel
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

Review 5.  The RASSF1A tumor suppressor.

Authors:  Howard Donninger; Michele D Vos; Geoffrey J Clark
Journal:  J Cell Sci       Date:  2007-09-15       Impact factor: 5.285

Review 6.  Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents.

Authors:  Jiahuai Tan; Shundong Cang; Yuehua Ma; Richard L Petrillo; Delong Liu
Journal:  J Hematol Oncol       Date:  2010-02-04       Impact factor: 17.388

7.  Reactivation of the silenced thyroid hormone receptor β gene expression delays thyroid tumor progression.

Authors:  Won Gu Kim; Xuguang Zhu; Dong Wook Kim; Lisa Zhang; Electron Kebebew; Sheue-Yann Cheng
Journal:  Endocrinology       Date:  2012-11-26       Impact factor: 4.736

8.  Methylation status of genes in papillary thyroid carcinoma.

Authors:  Jason A Smith; Chun-Yang Fan; Chunlai Zou; Donald Bodenner; Mimi S Kokoska
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2007-10

9.  Methylation Markers for Early Detection and Differentiation of Follicular Thyroid Cancer Subtypes.

Authors:  Josena K Stephen; Kang Mei Chen; Jason Merritt; Dhananjay Chitale; George Divine; Maria J Worsham
Journal:  Cancer Clin Oncol       Date:  2015-06-15

10.  Analysis of loss of heterozygsity effect on thyroid tumor with oxyphilia cell locus in familial non medullary thyroid carcinoma in Iranian families.

Authors:  Hasti Atashi Shirazi; Mehdi Hedayati; Maryam Sadat Daneshpour; Abdollah Shafiee; Fereidoun Azizi
Journal:  Indian J Hum Genet       Date:  2012-09
View more
  16 in total

Review 1.  LncRNAs and miRs as epigenetic signatures in diabetic cardiac fibrosis: new advances and perspectives.

Authors:  Hui Tao; Zheng-Yu Song; Xuan-Sheng Ding; Jing-Jing Yang; Kai-Hu Shi; Jun Li
Journal:  Endocrine       Date:  2018-07-27       Impact factor: 3.633

2.  The Epigenetic Modification of SLC5A8 in Papillary Thyroid Carcinoma and its Effects on Clinic-Pathological Features.

Authors:  Sara Sheikholeslami; Fereidoun Azizi; Asghar Ghasemi; Abbas Alibakhshi; Hossein Parsa; Setareh Shivaee; Marjan Zarif-Yeganeh; Mehdi Hedayati; Ladan Teimoori-Toolabi
Journal:  Iran J Public Health       Date:  2022-03       Impact factor: 1.479

Review 3.  Research Progress of Traditional Chinese Medicine in Treatment of Myocardial fibrosis.

Authors:  Chunzhen Ren; Kai Liu; Xinke Zhao; Huan Guo; Yali Luo; Juan Chang; Xiang Gao; Xinfang Lv; Xiaodong Zhi; Xue Wu; Hugang Jiang; Qilin Chen; Yingdong Li
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

Review 4.  Role of Emerging Environmental Risk Factors in Thyroid Cancer: A Brief Review.

Authors:  Maria Fiore; Gea Oliveri Conti; Rosario Caltabiano; Antonino Buffone; Pietro Zuccarello; Livia Cormaci; Matteo Angelo Cannizzaro; Margherita Ferrante
Journal:  Int J Environ Res Public Health       Date:  2019-04-02       Impact factor: 3.390

Review 5.  Regulators of glucose uptake in thyroid cancer cell lines.

Authors:  Shabnam Heydarzadeh; Ali Asghar Moshtaghie; Maryam Daneshpoor; Mehdi Hedayati
Journal:  Cell Commun Signal       Date:  2020-06-03       Impact factor: 5.712

6.  Bioinformatic analysis and identification of potential prognostic microRNAs and mRNAs in thyroid cancer.

Authors:  Jianing Tang; Deguang Kong; Qiuxia Cui; Kun Wang; Dan Zhang; Qianqian Yuan; Xing Liao; Yan Gong; Gaosong Wu
Journal:  PeerJ       Date:  2018-05-04       Impact factor: 2.984

Review 7.  DICER1 Syndrome: DICER1 Mutations in Rare Cancers.

Authors:  Jake C Robertson; Cheryl L Jorcyk; Julia Thom Oxford
Journal:  Cancers (Basel)       Date:  2018-05-15       Impact factor: 6.639

Review 8.  Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis.

Authors:  Veronica Veschi; Francesco Verona; Melania Lo Iacono; Caterina D'Accardo; Gaetana Porcelli; Alice Turdo; Miriam Gaggianesi; Stefano Forte; Dario Giuffrida; Lorenzo Memeo; Matilde Todaro
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-25       Impact factor: 5.555

9.  HDAC1 and HDAC2 Double Knockout Triggers Cell Apoptosis in Advanced Thyroid Cancer.

Authors:  Ching-Ling Lin; Ming-Lin Tsai; Chun-Yu Lin; Kai-Wen Hsu; Wen-Shyang Hsieh; Wei-Ming Chi; Li-Chi Huang; Chia-Hwa Lee
Journal:  Int J Mol Sci       Date:  2019-01-21       Impact factor: 6.208

Review 10.  Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice.

Authors:  Elena Tirrò; Federica Martorana; Chiara Romano; Silvia Rita Vitale; Gianmarco Motta; Sandra Di Gregorio; Michele Massimino; Maria Stella Pennisi; Stefania Stella; Adriana Puma; Fiorenza Gianì; Marco Russo; Livia Manzella; Paolo Vigneri
Journal:  Genes (Basel)       Date:  2019-09-13       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.